(Patient Q&A #1) One of the most frequent questions gastroenterologists encounter is regarding the specific nature of the pain
The fact that it is not yet standard for GLP-1 users reflects the lower, though still elevated, risk level
This is because tirzepatide is designed to mimic the action of two gut hormones, glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which are released in response to food intake and help to regulate blood sugar levels
GLP-1 receptor agonists predominantly target non-MC4R-dependent neural pathways in mice 19 , and there is evidence from a small clinical study with liraglutide 20 that they may be effective in people with MC4R deficiency
The slightly higher serious adverse event rate with tirzepatide in SURPASS-2 has not raised safety concerns in subsequent, larger trials
Tirzepatide Pregnancy Warnings This drug should be used during pregnancy only if the benefit outweighs the risk to the fetus